FU Li-xian,LIN Shao-mei. Clinical significance of serum fibrosis index detection in 62 patients with pulmonary tuberculosis[J]. Chinese Journal of Antituberculosis, 2014, 36(12): 1080-1083. doi: 10.3969/j.issn.1000-6621.2014.12.016
[1]Wynn TA. Cellular and molecular mechanisms of fibrosis. J Pathol, 2008, 214(2): 199-210.[2]陈玉龙,戈川. 肺结核患者血清纤维化指标与肺通气功能的相关性研究.中国防痨杂志,2007,29(3):249-251.[3]中华医学会结核病学分会.肺结核诊断和治疗指南.中华结核和呼吸杂志,2001,24(2):70-74.[4]周新华.重视结核病的影像学分析与影像技术.中国防痨杂志,2014,36(3):145-148.[5]张艳林,吴立盘,张飞龙. 胸部 CT 对中西药联合治疗肺结核的临床价值分析. 临床合理用药,2013,6(11A):127-128.[6]秦新海,南德齐.肺结核患者治疗前后血清TNF和HA含量的变化. 放射免疫学杂志, 2001,14 (2):114-115.[7]吴艳凌,吕炜.肺结核患者治疗前后血清HA、PⅢP含量.放射免疫学杂志,2003,16(5):281-282.[8]Wallace WA, Fitch PM, Simpson AJ, et al. Inflammation-associated remodelling and fibrosis in the lung—a process and an end point. Int J Exp Pathol, 2007, 88(2): 103-110.[9]王辉,陈雪芬,魏路清.肺纤维化发病机制新进展.武警后勤学院学报,2013,22(1):69-73.[10]Keane MP, Strieter RM, Belperio JA. Mechanisms and mediators of pulmonary fibrosis. Crit Rev Immunol, 2005,25(6):429-463.[11]崔兰英,陈裕华,刘咏梅.肺结核复发的病因分析与防治策略.临床医学工程,2012,19(2):239-240.